Therapeutics News and Research

RSS

CD22-targeted CAR-T therapy shows promising results in relapsed large B-cell lymphoma

CAR-T cell therapy, which targets a specific protein on the surface of cancer cells, causes tumors to shrink or disappear in about half of patients with large B-cell lymphoma who haven't experienced improvement with chemotherapy treatments.

11 Jul 2024

Prime editing offers promising path to permanent treatment for cystic fibrosis

Cystic fibrosis is one of the most common genetic disorders, causing thick mucus build-up in the lungs and other parts of the body, breathing problems, and infection.

11 Jul 2024

Novel Co-STAR cells show promise in targeting and eradicating cancer

Using genetic engineering techniques, investigators at the Johns Hopkins Kimmel Cancer Center and its Ludwig Center, the Lustgarten Laboratory and Bloomberg~Kimmel Institute for Cancer Immunotherapy have designed a novel type of cell to recognize and fight cancer.

11 Jul 2024

New gene editing technique offers hope for millions

A team led by Mass Eye and Ear researchers has demonstrated for the first time a successful restoration of hearing through a novel, in vivo genome editing approach in an adult mouse model with a form of inherited deafness caused by mutations in microRNA.

11 Jul 2024

Novel molecule could inform new therapies for stroke-related brain injury

A newly developed molecule, LK-2, could inform new therapies for stroke-related brain injury, finds scientists at The Hospital for Sick Children (SickKids).

10 Jul 2024

Click-like chemistry enables rapid development of LNPs for enhanced mRNA delivery

Imagine a scenario where a skilled hacker must upload critical software to update a central server and thwart a potentially lethal virus from wreaking havoc across a vast computer network.

10 Jul 2024

Antonin (Tony) de Fougerolles appointed as new Chair of etherna

etherna, a leading mRNA technologies company, today announced the appointment of Antonin (Tony) de Fougerolles as Chair. Tony has served as an Independent Board Member since January 2023.

From etherna 10 Jul 2024

60 years in the making: Nanoparticles revolutionize nucleotide delivery

Researchers trace the 60-year evolution of lipid nanoparticles (LNPs) for nucleic acid delivery, highlighting their potential to revolutionize gene therapy with safer and more effective treatments.

10 Jul 2024

Enzyme breakthrough could revolutionize the production of greener cancer treatments

Scientists from The University of Manchester have uncovered a more efficient and sustainable way to make peptide-based medicines, showing promising effectiveness in combating cancers.

10 Jul 2024

Fungal endophytes: A promising frontier for breast cancer treatment

A recent study in Heliyon highlights the potential of fungal endophytes in developing novel anti-cancer agents, specifically targeting breast cancer therapy.

10 Jul 2024

Osteoarthritis linked to accelerated progression of severe long-term conditions

Osteoarthritis - a condition in which the protective cartilage on the ends of bones breaks down - may more than double the risk of speedy progression to accumulating severe long term conditions (multimorbidity), finds a 20 year study published in the open access journal RMD Open.

9 Jul 2024

Transforming growth factor beta inhibition boosts NK cell therapy against hepatocellular carcinoma

Researchers at University of California San Diego have found that the most common form of liver cancer - one with a high mortality rate - can be better targeted and treated using an innovative new stem cell-derived therapy, according to a recently published study in Cell Stem Cell.

9 Jul 2024

Study uncovers a potential treatment for food allergies in a naturally occurring plant fiber

A study from the University of Michigan has identified a potential new treatment for food allergies in inulin, a naturally occurring plant fiber commonly used as a supplement, a prebiotic in soda, a replacement for sweeteners and for other products and purposes.

9 Jul 2024

Combined use of popular diabetes drugs likely to offer additional protection against heart and kidney disease

New research shows combined use of sodium glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP1-RAs) is likely to offer additional protection against heart and kidney disease in patients with diabetes.

8 Jul 2024

Smartphone-based behavioral therapy leads to improvements for patients with fibromyalgia

New research led by the University of Cincinnati and Swing Therapeutics found that a self-guided smartphone-based behavioral therapy led to significant improvements for patients with fibromyalgia.

8 Jul 2024

Breakthrough humanized mouse model offers new insights for immunotherapy development

A breakthrough for biomedical research promises new insight into immunotherapy development and disease modeling.

5 Jul 2024

Innovative study on gut bacteria and T cells wins NOSTER & Science Microbiome Prize

In the gut, dozens of strains of bacteria exert different effects on the immune system that in turn impact our health – fending off pathogens, helping digest food and maybe even influencing behavior. But pinpointing which bacteria exert which effects has been challenging.

4 Jul 2024

Therapeutics News and Research

CD22-targeted CAR-T therapy shows promising results in relapsed large B-cell lymphoma

Prime editing offers promising path to permanent treatment for cystic fibrosis

Novel Co-STAR cells show promise in targeting and eradicating cancer

New gene editing technique offers hope for millions

Novel molecule could inform new therapies for stroke-related brain injury

Click-like chemistry enables rapid development of LNPs for enhanced mRNA delivery

Antonin (Tony) de Fougerolles appointed as new Chair of etherna

60 years in the making: Nanoparticles revolutionize nucleotide delivery

Enzyme breakthrough could revolutionize the production of greener cancer treatments

Fungal endophytes: A promising frontier for breast cancer treatment

Osteoarthritis linked to accelerated progression of severe long-term conditions

Transforming growth factor beta inhibition boosts NK cell therapy against hepatocellular carcinoma

Study uncovers a potential treatment for food allergies in a naturally occurring plant fiber

Combined use of popular diabetes drugs likely to offer additional protection against heart and kidney disease

Smartphone-based behavioral therapy leads to improvements for patients with fibromyalgia

Breakthrough humanized mouse model offers new insights for immunotherapy development

Innovative study on gut bacteria and T cells wins NOSTER & Science Microbiome Prize

Turning cancer cells against themselves to overcome drug resistance

Repurposing cancer drug to prevent organ damage in infectious diseases

Protein nanocages: A promising frontier in mRNA therapeutics

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News